Drug profile · INN
sugammadex sodium
SUGAMMADEX LORIEN
sugammadex sodium (SUGAMMADEX LORIEN) is a rocuronium sequestering agent. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — sugammadex sodium
- US status
- approved
- Class
- Various (V03)
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
sugammadex sodium (SUGAMMADEX LORIEN) is a rocuronium sequestering agent. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Rocuronium sequestering agent
Primary target: Rocuronium
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | application withdrawn | — |
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sugammadex sodium?
sugammadex sodium (SUGAMMADEX LORIEN) is a rocuronium sequestering agent. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sugammadex sodium?
SUGAMMADEX LORIEN is a marketed brand name for sugammadex sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sugammadex sodium?
sugammadex sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.